• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异吲哚-1-酮衍生物作为脲酶抑制剂的设计、合成、生物评价、分子对接和计算机 ADME 评价。

Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation.

机构信息

School of Chemistry, College of Science, University of Tehran, PO Box 14155-6455, Tehran, Iran.

School of Chemistry, College of Science, University of Tehran, PO Box 14155-6455, Tehran, Iran.

出版信息

Bioorg Chem. 2019 Jun;87:1-11. doi: 10.1016/j.bioorg.2019.02.051. Epub 2019 Feb 25.

DOI:10.1016/j.bioorg.2019.02.051
PMID:30852231
Abstract

An efficient, one-pot and four-component synthesis of a new series of 2,3-disubstituted isoindolin-1-ones is described and their Jack bean urease inhibitory activities are evaluated. Heating a mixture of 1,1-bis(methylthio)-2-nitroethene, a 1,2-diamine, a 2-formylbenzoic acid and a primary amine in EtOH for 3.5 h afforded the corresponding 2,3-disubstituted isoindolin-1-ones in good to excellent yields. All sixteen synthesized isoindolin-1-one derivatives 5a-p showed urease inhibitory activity. Among them, 5c showed the most urease inhibitory activity (IC = 10.07 ± 0.28 µM) being over 2-fold more potent than thiourea (IC = 22.01 ± 0.10 µM) and 10-fold than hydroxyurea (IC = 100.00 ± 0.02 µM) as the standard inhibitors, respectively. Also, results from molecular docking studies were in good agreement with those obtained from in vitro tests.

摘要

描述了一种高效、一锅法和四组分合成一系列新型 2,3-二取代异吲哚啉-1-酮的方法,并评价了它们对刀豆脲酶的抑制活性。将 1,1-双(甲硫基)-2-硝基乙烯、1,2-二胺、2-甲酰苯甲酸和伯胺的混合物在乙醇中加热 3.5 小时,以良好至优异的收率得到相应的 2,3-二取代异吲哚啉-1-酮。所合成的 16 个异吲哚啉-1-酮衍生物 5a-p 均表现出脲酶抑制活性。其中,5c 的脲酶抑制活性最强(IC=10.07±0.28μM),比硫脲(IC=22.01±0.10μM)强 2 倍,比羟脲(IC=100.00±0.02μM)强 10 倍,分别作为标准抑制剂。此外,分子对接研究的结果与体外试验的结果吻合良好。

相似文献

1
Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation.异吲哚-1-酮衍生物作为脲酶抑制剂的设计、合成、生物评价、分子对接和计算机 ADME 评价。
Bioorg Chem. 2019 Jun;87:1-11. doi: 10.1016/j.bioorg.2019.02.051. Epub 2019 Feb 25.
2
Flavonoid analogues as urease inhibitors: Synthesis, biological evaluation, molecular docking studies and in-silico ADME evaluation.类黄酮类似物作为脲酶抑制剂的合成、生物评价、分子对接研究和计算机 ADME 评价。
Bioorg Chem. 2020 Dec;105:104370. doi: 10.1016/j.bioorg.2020.104370. Epub 2020 Oct 12.
3
Semicarbazone derivatives as urease inhibitors: Synthesis, biological evaluation, molecular docking studies and in-silico ADME evaluation.脒基腙衍生物作为脲酶抑制剂的合成、生物评价、分子对接研究和体内 ADME 评价。
Bioorg Chem. 2018 Sep;79:19-26. doi: 10.1016/j.bioorg.2018.03.029. Epub 2018 Apr 18.
4
4-Aminocoumarin based Aroylthioureas as Potential Jack Bean Urease Inhibitors; Synthesis, Enzyme Inhibitory Kinetics and Docking Studies.基于4-氨基香豆素的芳酰基硫脲作为潜在的刀豆脲酶抑制剂;合成、酶抑制动力学及对接研究
Med Chem. 2020;16(2):229-243. doi: 10.2174/1573406415666190715164834.
5
Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors.设计、合成、分子对接研究及 4-(3-苯甲酰基硫脲基)苯甲酸乙酯的体外筛选作为脲酶抑制剂。
Bioorg Chem. 2014 Feb;52:1-7. doi: 10.1016/j.bioorg.2013.10.001. Epub 2013 Oct 30.
6
Synthesis and characterization of new thiosemicarbazones, as potent urease inhibitors: In vitro and in silico studies.新型缩硫代氨基脲的合成与表征及其作为有效脲酶抑制剂的研究:体外和计算研究。
Bioorg Chem. 2019 Jun;87:155-162. doi: 10.1016/j.bioorg.2019.03.008. Epub 2019 Mar 6.
7
Synthesis and molecular docking study of some novel 2,3-disubstituted quinazolin-4(3H)-one derivatives as potent inhibitors of urease.一些新型 2,3-二取代喹唑啉-4(3H)-酮衍生物的合成及分子对接研究作为脲酶抑制剂的潜力。
Bioorg Chem. 2018 Oct;80:121-128. doi: 10.1016/j.bioorg.2018.06.011. Epub 2018 Jun 4.
8
Design, synthesis, in vitro Evaluation and docking studies on dihydropyrimidine-based urease inhibitors.基于二氢嘧啶的脲酶抑制剂的设计、合成、体外评价及对接研究
Bioorg Chem. 2017 Oct;74:53-65. doi: 10.1016/j.bioorg.2017.07.003. Epub 2017 Jul 19.
9
Synthesis, Biological Evaluation and Molecular Docking of Deferasirox and Substituted 1,2,4-Triazole Derivatives as Novel Potent Urease Inhibitors: Proposing Repositioning Candidate.地拉罗司和取代 1,2,4-三唑衍生物的合成、生物评价及分子对接作为新型强效脲酶抑制剂的研究:重新定位候选药物的提出。
Chem Biodivers. 2020 May;17(5):e1900710. doi: 10.1002/cbdv.201900710. Epub 2020 Apr 21.
10
Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.一些带有三唑、恶二唑和亚胺官能团的5,6-二氯-2-环丙基-1H-苯并咪唑衍生物作为脲酶有效抑制剂的合成及分子对接研究
Bioorg Med Chem Lett. 2017 Jul 1;27(13):3014-3018. doi: 10.1016/j.bmcl.2017.05.019. Epub 2017 May 10.

引用本文的文献

1
Electrochemical-Induced Cascade Reaction of 2-Formyl Benzonitrile with Anilines: Synthesis of -Aryl Isoindolinones.电化学诱导 2-甲酰苯腈与苯胺的级联反应:-芳基异吲哚啉酮的合成。
Molecules. 2022 Nov 24;27(23):8199. doi: 10.3390/molecules27238199.
2
Isoindolin-1-ones from the stems of Nicotiana tabacum and their antiviral activities.从烟草茎中分离得到的异吲哚-1-酮及其抗病毒活性。
Arch Pharm Res. 2022 Aug;45(8):572-583. doi: 10.1007/s12272-022-01399-x. Epub 2022 Aug 20.
3
Isoindolin-1-ones Fused to Barbiturates: From Design and Molecular Docking to Synthesis and Urease Inhibitory Evaluation.
与巴比妥酸稠合的异吲哚啉-1-酮:从设计、分子对接至合成及脲酶抑制活性评估
ACS Omega. 2022 Jun 2;7(23):19401-19411. doi: 10.1021/acsomega.2c01028. eCollection 2022 Jun 14.
4
Asymmetric Cascade Aza-Henry/Lactamization Reaction in the Highly Enantioselective Organocatalytic Synthesis of 3-(Nitromethyl)isoindolin-1-ones from α-Amido Sulfones.不对称级联氮杂 Henry 反应/内酰胺化反应在手性有机催化的α-酰胺砜构建 3-(硝甲基)异吲哚啉-1-酮中的高对映选择性合成
J Org Chem. 2022 Jul 1;87(13):8420-8428. doi: 10.1021/acs.joc.2c00518. Epub 2022 Jun 14.
5
Structural Insights from Molecular Modeling of Isoindolin-1-One Derivatives as PI3Kγ Inhibitors against Gastric Carcinoma.异吲哚啉-1-酮衍生物作为PI3Kγ抑制剂抗胃癌的分子模拟结构见解
Biomedicines. 2022 Mar 30;10(4):813. doi: 10.3390/biomedicines10040813.